Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Chronic central retinal artery occlusion: Clinical manifestations, ocular neovascular complications, and risk of
Jae Ryong Song1,2, Se Joon Woo2
1Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Insights
About a quarter of central retinal artery occlusion (CRAO) patients develop chronic CRAO, increasing stroke risk and neovascular complications. Persistent retinal ischemia in chronic CRAO warrants close monitoring and systemic evaluation.
Area of Science:
- Ophthalmology
- Vascular Medicine
- Neurology
Background:
- Central retinal artery occlusion (CRAO) is a critical condition with potential for long-term ischemic damage.
- Chronic CRAO, defined by persistent retinal ischemia over a month post-onset, presents unique challenges.
- Understanding the progression and complications of chronic CRAO is vital for patient management.
Purpose of the Study:
- To investigate the clinical characteristics of chronic CRAO.
- To assess neovascular complications and stroke risk in chronic CRAO patients.
- To differentiate outcomes based on perfusion status in chronic CRAO.
Main Methods:
- Retrospective cohort study of 570 eyes diagnosed with acute non-arteritic CRAO.
- Inclusion criteria focused on 289 eyes meeting definitions for acute or chronic CRAO.
- Chronic CRAO was confirmed by fluorescein angiography showing persistent retinal ischemia (>1 month post-onset), categorized by delayed perfusion or nonperfusion.
Main Results:
- 25.6% of patients progressed to chronic CRAO.
- Chronic CRAO patients were older and had more comorbidities.
- Neovascularization of the iris and neovascular glaucoma were exclusive to chronic CRAO, with significantly higher rates in the nonperfusion subgroup (90% and 68%, respectively).
- Stroke risk was elevated in chronic CRAO patients compared to acute CRAO patients.
Conclusions:
- Approximately 25% of acute CRAO cases evolve into chronic CRAO.
- Chronic CRAO is linked to increased stroke risk and ocular neovascularization.
- Persistent retinal nonperfusion in chronic CRAO significantly elevates the risk of severe neovascular complications, highlighting the need for vigilant monitoring and systemic assessment.
Abstract:
Central retinal artery occlusion (CRAO) is a vision-threatening emergency that can lead to chronic ischemic complications. This retrospective cohort study investigated clinical characteristics, neovascular complications, and stroke risk in patients with chronic CRAO defined as the post-acute phase state characterized by FA-confirmed persistent retinal ischemia ≥1 month after acute onset. We reviewed medical records of 570 eyes initially diagnosed with acute non-arteritic CRAO between September 2003 and December 2024, with 289 eyes meeting inclusion criteria. Chronic CRAO was defined as persistent prolonged arm-to-retina or arteriovenous transit times on fluorescein angiography performed >1 month after symptom onset, and further classified as delayed perfusion or nonperfusion based on venous filling patterns. Among 289 patients, 215 eyes (74.4%) had acute CRAO with spontaneous reperfusion, while 74 eyes (25.6%) had chronic CRAO, including 55 eyes (74.3%) with delayed perfusion and 19 eyes (25.7%) with nonperfusion. Chronic CRAO patients were older with higher prevalence of systemic comorbidities. Previous stroke (43.2% vs. 26.0%, p = 0.009) and concurrent stroke (20.3% vs. 12.1%, p = 0.122) were more common in chronic CRAO patients compared to acute CRAO. Neovascularization of the iris occurred exclusively in chronic CRAO (32.4% vs. 0.0%, p < 0.001), with the nonperfusion group showing significantly higher rates of neovascularization of the iris (90% vs. 13%, p < 0.001) and neovascular glaucoma (68% vs. 9%, p < 0.001) compared to delayed perfusion group. Kaplan-Meier analysis revealed earlier onset of neovascularization in nonperfusion cases (median 1.6 months) with a 20-fold increased hazard ratio. Approximately one quarter of acute non-arteritic CRAO patients progress to chronic CRAO, which is associated with increased stroke risk and ocular neovascularization, particularly when retinal arterial nonperfusion persists. These findings emphasize the importance of fluorescein angiography monitoring and systemic evaluation in CRAO management.
Related Concept Videos
Glaucoma: Overview
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies

